AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ)
$2.37 -0.07 (-2.8689%)
Analysed AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) News Sources
Autolus Therapeutics (AUTL) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
10-06-2026
yahoo.com
Autolus Therapeutics Receives Prix Galien UK Award
12-06-2026
yahoo.com
Why Autolus Therapeutics (AUTL) Looks Less Speculative as AUCATZYL Revenue Builds
17-06-2026
yahoo.com
Autolus Therapeutics to Participate in Upcoming Investor Conference
25-06-2026
yahoo.com
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01-07-2026
yahoo.com
Autolus Therapeutics (AUTL) Grants Inducement Awards to New Employees
14-07-2026
yahoo.com
Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors
03-08-2026
yahoo.com
Autolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026
03-08-2026
yahoo.com
Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
11-08-2026
yahoo.com
Autolus Therapeutics Q2 Earnings Call Highlights
11-08-2026
marketbeat.com
What is the current price of AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ)?
The current price of AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) is $2.37.
AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) absolute price change since previous trading day?
The absolute price change of AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) since the previous trading day is $-0.07.
AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) percentage price change since previous trading day?
The percentage price change of AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) since the previous trading day is -2.8689%.
What is the most recent average sentiment score for AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ)?
The most recent average sentiment score for AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ)?
The most recent sentiment for AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) is .
SEC-8K** Filing Available For AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.